Name: Actinogen Medical (ACW) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

ACW

Actinogen Medical

Pharmaceuticals, Biotechnology & Life Sciences

Actinogen Medical Limited focuses on the development and commercialization of novel therapeutic compounds, specifically targeting central nervous system diseases. Positioned as an innovative player in the biotechnology sector, Actinogen's flagship product, Xanamem, aims to treat Alzheimer's Disease and other neurodegenerative conditions, offering a unique therapeutic approach in a growing market. Their commitment to addressing unmet medical needs through rigorous clinical trials sets them apart from traditional pharmaceutical providers.

Short position

short percentage0.00%

reported shorts10K

shares on issue3.658B

Actinogen Medical (ASX:ACW) has 0.00% of its shares on issue reported as short positions as of 25 May 2026, or about 9,980 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.19% in April 2015. ACW is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.